Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sundar

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.
ESMO Open|October 19, 2024
Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroupsA G Leone, A S Mai, K Y Fong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Efficacy of Oral SERDs in the treatment of ER+, HER2 - metastatic breast cancer, a stratified analysis of the ESR1 wild type and mutant subgroupsN Z H Wong, D W T Yap, R J M Ong, et al.
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerB Basu, M G Krebs, R Sundar, et al.
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Sexually dimorphic mechanisms of VGLUT-mediated protection from dopaminergic neurodegenerationSilas A Buck, Sophie A Rubin, Tenzin Kunkhyen, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.
ESMO Open|October 19, 2024
Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroupsA G Leone, A S Mai, K Y Fong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Efficacy of Oral SERDs in the treatment of ER+, HER2 - metastatic breast cancer, a stratified analysis of the ESR1 wild type and mutant subgroupsN Z H Wong, D W T Yap, R J M Ong, et al.
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerB Basu, M G Krebs, R Sundar, et al.
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Sexually dimorphic mechanisms of VGLUT-mediated protection from dopaminergic neurodegenerationSilas A Buck, Sophie A Rubin, Tenzin Kunkhyen, et al.
Pageof 3